US Stock MarketDetailed Quotes

SGMT Sagimet Biosciences

Watchlist
  • 4.200
  • +0.050+1.20%
Trading Jan 24 12:59 ET
135.22MMarket Cap-3.61P/E (TTM)

About Sagimet Biosciences Company

Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.

Company Profile

SymbolSGMT
Company NameSagimet Biosciences
Listing DateJul 14, 2023
Issue Price16.00
Founded2006
CEOMr. David Happel
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address155 Bovet Road,Suite 303
CitySan Mateo
ProvinceCalifornia
CountryUnited States of America
Zip Code94402
Phone1-650-561-8600
Websitehttp://www.sagimet.com

Company Executives

  • Name
  • Position
  • Salary
  • David Happel
  • President, Chief Executive Officer and Director
  • 2.69M
  • Dr. Eduardo Bruno Martins, D.Phil.,M.D.
  • Chief Medical Officer
  • 1.51M
  • Elizabeth Rozek
  • General Counsel and Chief Compliance Officer
  • --
  • Thierry Chauche
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • George Kemble, PhD
  • Executive Chairman of the Board
  • 930.22K
  • Dr. Anne M. Phillips, M.D.
  • Independent Director
  • --
  • Elizabeth Grammer
  • Independent Director
  • 43.00K
  • Dr. Merdad V. Parsey, M.D.,PhD
  • Independent Director
  • 41.50K
  • Jennifer Ann Jarrett
  • Independent Director
  • --
  • Dr. Beth C. Seidenberg,M.D.
  • Independent Director
  • 14.38K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
GVS
870976
+29.98%
Hangzhou CNCR-IT
300250
+20.03%
Shanghai Newtouch Software
688590
+20.01%
4
Ucap Cloud Information Technology Co.,Ltd
688228
+20.00%
5
Yangtze Optical Electronic
688143
+20.00%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Trump's comeback to the Office
Following Trump's Policies to Seek Investment Opportunities
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline? Show More
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011